These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 6804110

  • 21. Safety and efficacy of encainide for malignant ventricular arrhythmias.
    Tordjman T, Podrid PJ, Raeder E, Lown B.
    Am J Cardiol; 1986 Aug 29; 58(5):87C-95C. PubMed ID: 3092625
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Comparison of the effects of placebo and encainide on programmed electrical stimulation and ventricular arrhythmia frequency.
    Duff HJ, Roden DM, Dawson AK, Oates JA, Smith RF, Woosley RL.
    Am J Cardiol; 1982 Aug 29; 50(2):305-12. PubMed ID: 6808820
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Drug conversion of nonsustained ventricular tachycardia to sustained ventricular tachycardia during serial electrophysiologic studies: identification of drugs that exacerbate tachycardia and potential mechanisms.
    Rinkenberger RL, Prystowsky EN, Jackman WM, Naccarelli GV, Heger JJ, Zipes DP.
    Am Heart J; 1982 Feb 29; 103(2):177-84. PubMed ID: 6798855
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Suppression of incessant supraventricular tachycardia by intravenous and oral encainide.
    Brugada P, Abdollah H, Wellens HJ.
    J Am Coll Cardiol; 1984 Dec 29; 4(6):1255-60. PubMed ID: 6438205
    [Abstract] [Full Text] [Related]

  • 30. Treatment of atrioventricular node reentrant tachycardia with encainide: reversal of drug effect with isoproterenol.
    Niazi I, Naccarelli G, Dougherty A, Rinkenberger R, Tchou P, Akhtar M.
    J Am Coll Cardiol; 1989 Mar 15; 13(4):904-10. PubMed ID: 2494243
    [Abstract] [Full Text] [Related]

  • 31. Effects of encainide and metabolizer phenotype on ventricular conduction during exercise.
    Karalis DG, Nydegger C, Porter RS, Carver J, Pina IL, Kutalek SP, Michelson EL.
    Am J Cardiol; 1990 Dec 01; 66(19):1393-6. PubMed ID: 2123075
    [No Abstract] [Full Text] [Related]

  • 32. [Anti-arrhythmia and electrophysiological effects of encainide in supraventricular tachycardias].
    Cassagneau B, Miquel JP, Puel JP, Mordant B, Kher A, Fauvel JM, Bounhoure JP.
    Arch Mal Coeur Vaiss; 1985 Oct 01; 78 Spec No():113-9. PubMed ID: 3938253
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Reversal of proarrhythmic effects of flecainide acetate and encainide hydrochloride by propranolol.
    Myerburg RJ, Kessler KM, Cox MM, Huikuri H, Terracall E, Interian A, Fernandez P, Castellanos A.
    Circulation; 1989 Dec 01; 80(6):1571-9. PubMed ID: 2480856
    [Abstract] [Full Text] [Related]

  • 35. Long-term efficacy and safety of oral encainide in the treatment of chronic ventricular ectopic activity: relationship to plasma concentrations--a French multicenter trial.
    Dumoulin P, Jaillon P, Kher A, Poirier JM, Cheymol G, Valty J, Flammang D, Coumel P, Medvedowsky JL, Barnay C.
    Am Heart J; 1985 Sep 01; 110(3):575-81. PubMed ID: 2412428
    [Abstract] [Full Text] [Related]

  • 36. Antiarrhythmic efficacy of encainide in patients with refractory recurrent ventricular tachycardia.
    Mason JW, Peters FA.
    Circulation; 1981 Mar 01; 63(3):670-5. PubMed ID: 6780234
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Hemodynamic and electrophysiologic effects of encainide in patients with bundle branch block.
    Schwartz AB, Shapiro WA, Suave MJ, Shen E, Bhandari A, Morady F, Scheinman M.
    Can J Cardiol; 1987 Mar 01; 3(2):75-82. PubMed ID: 3105850
    [Abstract] [Full Text] [Related]

  • 39. Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS.
    Cardiac Arrhythmia Pilot Study (CAPS) InvestigatorsThe CAPS Coordinating Center, University of Washington, JD-22, 1107 Northeast 45th, Room 505, Seattle, Washington 98105, USA..
    Am J Cardiol; 1988 Mar 01; 61(8):501-9. PubMed ID: 2894169
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.